Add-on vigabatrin in children with refractory epilepsy. A 4-year follow-up study

Clinical Drug Investigation

Volumn 12, Issue 6, 1996, Pages 287-297

  Arteaga, Rosa ^a   Herranz, José L ^a   Armijo, Juan A ^a,b  

^a UNIVERSITY OF CANTABRIA   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ANTICONVULSIVE AGENT; VIGABATRIN;

ADOLESCENT; ADULT; AGGRESSIVENESS; APATHY; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DROWSINESS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG TOLERABILITY; EPILEPSY; FATIGUE; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEIZURE; SINGLE BLIND PROCEDURE;

EID: 0029974004     PISSN: 11732563     EISSN: None     Source Type: Journal    
DOI: 10.2165/00044011-199612060-00002     Document Type: Article

References (35)

1. Jung MJ, Lippert B, Metcalf BW, et al. Gamma-vinyl GABA (4-amino-hex-5-enoic acid), a new selective irreversible inhibitor of GABA-T: effects on brain GABA metabolism in mice. J Neurochem 1977; 29: 797-802
2. Metcalf BW. Inhibitors of GABA metabolism. Biochem Pharmacol 1979; 28: 1705-12
3. Duncan JS. Vigabatrin. In: Trimble MR, editor. New anticonvulsants: advances in the treatment of epilepsy. Chichester: John Wiley & Sons, 1994: 113-25
4. Dam M. Long-term evaluation of vigabatrin (gamma vinyl GABA) in epilepsy. Epilepsia 1989; 30 Suppl. 3: 26-30
5. Remy C, Beaumont D. Efficacy and safety of vigabatrin in the long-term treatment of refractory epilepsy. Br J Clin Pharmacol 1989; 27 Suppl. 1: 125-9
6. Cocito L, Maffini M, Perfumo P, et al. Vigabatrin in complex partial seizures: a long-term study. Epilep Res 1989; 3: 160-6
7. Tartara A, Manni R, Galimberti CA, et al. Vigabatrin in the treatment of epilepsy: a long-term follow-up study. J Neurol Neurosurg Psychiatry 1989; 52: 467-71
8. Grünewald RA, Thompson PJ, Corcoran R, et al. Effects of vigabatrin on partial seizures and cognitive function. J Neurol Neurosurg Psychiatry 1994; 57: 1057-63
9. Browne TR, Mattson RH, Penry JK, et al. Multicenter long-term safety and efficacy study of vigabatrin for refractory complex partial seizures: an update. Neurology 1991; 41: 363-4
10. Reynolds EH, Ring HA, Farr IN, et al. Open, double-blind and long-term study of vigabatrin in chronic epilepsy. Epilepsia 1991; 32: 530-8
11. Sivenius J, Ylinen A, Murros K, et al. Vigabatrin in drug-resistant partial epilepsy: a 5-year follow-up period. Neurology 1991; 41: 562-5
12. Pitkänen A, Ylinen A, Matilainen R, et al. Long-term antiepileptic efficacy of vigabatrin in drug-refractory epilepsy in mentally retarded patients. A 5-year follow-up study. Arch Neurol 1993; 50: 24-9
13. Livingston JH, Beaumont D, Arzimanoglou A, et al. Vigabatrin in the treatment of epilepsy in children. Br J Clin Pharmacol 1989; 27 Suppl. 1: 109-12
14. Luna D, Dulac O, Pajot N, et al. Vigabatrin in the treatment of childhood epilepsies: a single-blind placebo-controlled study. Epilepsia 1989; 30: 430-7
15. Dulac O, Chiron C, Luna D, et al. Vigabatrin in childhood epilepsy. J Child Neurol 1991; 6 Suppl. 2: 30-7
16. Herranz JL, Arteaga R, Farr IN, et al. Dose-response study of vigabatrin in children with refractory epilepsy. J Child Neurol 1991; 6 Suppl. 2: 45-51
17. Uldall P, Alving J, Gram L, et al. Vigabatrin in pediatric epilepsy - an open study. J Child Neurol 1991; 6 Suppl. 2: 38-44
18. Gibbs JM, Appleton RE, Rosenbloom L. Vigabatrin in intractable childhood epilepsy: a retrospective study. Pediatr Neurol 1992; 8: 338-40
19. Dalla Bernardina B, Simeone M, Fontana E, et al. Il vigabatrin nel trattamento delle epilessie infantili: a proposito di 49 osservazioni personali. Boll Lega It Epil 1992; 79/80: 311-2
20. Schmitz-Moormann W, Kruse R. Vigabatrin-langzeittherapie bei symptomatischen epilepsien mit komplex-fokalen anfällen im kindesalter. Akt Neurol 1992; 19 Suppl. 1: 23-5
21. Curatolo P. Vigabatrin for refractory partial seizures in children with tuberous sclerosis. Neuropediatrics 1994; 25: 55
22. Feucht M, Brantner-Inthaler S. Gamma-vinyl-GABA (vigabatrin) in the therapy of Lennox-Gastaut syndrome: an open study. Epilepsia 1994; 35: 993-8
23. Uldall P, Alving J, Gram L, et al. Vigabatrin in childhood epilepsy: a 5-year follow-up study. Neuropediatrics 1995; 26: 253-6
24. Laub MC. Vigabatrin zur behandlung therapieresistenter epilepsien im kindes- und jugendalter. Monatsschr Kinderheilkd 1995; 143: 496-9
25. Dalla Bernardina B, Fontana E, Vigevano F, et al. Efficacy and tolerability of vigabatrin in children with refractory partial seizures: a single-blind dose-increasing study. Epilepsia 1995; 36 (7): 687-91
26. Sheth RD, Buckley D, Penney S, et al. Vigabatrin in childhood epilepsy: comparable efficacy for generalized and partial seizures. Clin Neuropharmacol 1996; 19 (4): 297-304
27. Aicardi J, Sabril IS investigator and peer review groups, Mumford JP, et al. Vigabatrin as initial therapy for infantile spasms: a European retrospective survey. Epilepsia 1996; 37 (7): 638-42
28. Appleton RE. The role of vigabatrin in the management of infantile epileptic syndromes. Neurology 1993; 43 Suppl. 5: 21-3
29. White HL. 4-Aminobutyrate: 2-oxoglutarate aminotransferase in blood platelets. Science 1979; 205: 696-8
30. Eslami M, Stuart JD, Dean RW. Analysis of taurine in blood plasma of epileptic patients using an improved isocratic HPLC method for amino acids. J Liq Chromatogr 1987; 10: 977-95
31. Arteaga R, Herranz JL, Valdizán EM, et al. Gamma-vinyl-GABA (vigabatrin): relationship between dosage, plasma concentrations, platelet GABA-transaminase inhibition, and seizure reduction in epileptic children. Epilepsia 1992; 33: 923-31
32. Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin-phenol reagent. J Biol Chem 1951; 193: 265-75
33. Michelucci R, Tassinari CA. Response to vigabatrin in relation to seizure type. Br J Clin Pharmacol 1989; 27 Suppl. 1: 119-24
34. Berman RG, Vaughan VC, editors. Nelson textbook of pediatrics. Philadelphia: Saunders Co., 1991
35. Valdizán E, Armijo JA. Relationship between platelet and brain GABA transaminase inhibition by single and multiple doses of vigabatrin in rats. Epilepsia 1991; 32: 735-42